Tixel

What is Tixel®?

Tixel® is an innovative, non-laser thermal treatment that uses thermomechanical energy (TMA® technology) to safely and effectively treat meibomian gland dysfunction (MGD) and evaporative dry eye disease. This state-of-the-art technology is FDA-cleared and offers a non-invasive, no downtime solution for patients suffering from chronic dry eye symptoms related to eyelid inflammation and gland obstruction.

Dr. Jason Besecker is proud to be among the first providers in Idaho to offer Tixel® for the management of dry eye disease. Tixel® works by delivering brief, controlled pulses of thermal energy directly to the skin of the eyelids through a titanium tip that gently contacts the surface without penetrating or ablating tissue. This heat is transferred precisely and uniformly, stimulating collagen remodeling, reducing inflammation, and melting meibum within the meibomian glands.

By improving meibum flow and restoring gland functionality, Tixel® enhances tear film stability and ocular surface health. The result is a significant and sustained reduction in symptoms such as burning, grittiness, and irritation — addressing the root cause of evaporative dry eye.
​​​​​​​

Tixel® Procedure for Dry Eye

A standard treatment protocol consists of 3 sessions, typically spaced 2 weeks apart. Each treatment session lasts approximately 15 minutes.

Side Effects of Tixel® for Dry Eye

Tixel® is a safe and well-tolerated treatment with minimal downtime. Most side effects, if they occur, are minor and temporary. Possible reactions may include:

• Mild redness or warmth of the treated skin

• Temporary swelling or tenderness of the eyelids

• Light sensitivity

• Slight dryness or tightness of the skin

These effects typically resolve within 24–48 hours.

Contraindications of Tixel® for Dry Eye

(Non-inclusive list)

• Pregnancy or nursing

• Active ocular or periocular infection

• Recent ocular surgery or trauma

• Photosensitivity or use of photosensitizing medications

• Skin malignancy or suspicious lesions in the treatment area

• History of keloid formation or abnormal wound healing

• Uncontrolled systemic conditions affecting skin integrity

Who Should Consider Tixel® Treatment for Dry Eye

Tixel® is an excellent therapeutic option for patients with:

• Meibomian gland dysfunction (MGD)

• Ocular rosacea and eyelid inflammation

• Evaporative dry eye symptoms refractory to conventional therapies

• Poor response to artificial tears or prescription medications such as Xiidra, Restasis, or Cequa

• Desire for a non-laser, non-invasive, and clinically proven treatment to restore ocular comfort and health